J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):141-58. The - TopicsExpress



          

J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):141-58. The therapeutic role of niacin in dyslipidemia management. Boden WE, Sidhu MS, Toth PP. Abstract There is abundant epidemiologic evidence to support the independent, inverse relationship between low levels of high-density lipoprotein cholesterol (HDL-C) and incident cardiovascular (CV) risk, the clinical importance of which is underscored by the high prevalence of low HDL-C in populations with coronary heart disease (CHD), with or without elevated levels of low-density lipoprotein cholesterol (LDL-C). The National Cholesterol Education Program recommended that optimal treatment for high-risk patients includes both lowering LDL-C and non-HDL-C to risk stratified levels and raising HDL-C when it is
Posted on: Thu, 25 Dec 2014 19:45:01 +0000

Trending Topics



Recently Viewed Topics




© 2015